Adult Acute Megakaryoblastic Leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
38
|
4
|
0.020 |
None |
1.000 |
2 |
|
2008 |
2018 |
Myelodysplastic-Myeloproliferative Diseases
|
group |
Hemic and Lymphatic Diseases
|
Neoplastic Process
|
38
|
1
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Nasopharyngeal Neoplasms
|
group |
Neoplasms; Stomatognathic Diseases; Otorhinolaryngologic Diseases
|
Neoplastic Process
|
40
|
36
|
0.400 |
None |
1.000 |
2 |
1
|
2010 |
2016 |
Pulmonary function
|
phenotype |
|
Organ or Tissue Function
|
41
|
259
|
0.100 |
None |
1.000 |
1 |
1
|
2011 |
2011 |
Myelodysplastic Syndrome with Isolated del(5q)
|
disease |
Hemic and Lymphatic Diseases
|
Neoplastic Process
|
41
|
1
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Pulmonary function (finding)
|
phenotype |
|
Finding
|
41
|
259
|
0.100 |
None |
1.000 |
1 |
1
|
2011 |
2011 |
Chromosome 5, trisomy 5q
|
disease |
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nervous System Diseases
|
Disease or Syndrome
|
42
|
1
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Childhood Acute Megakaryoblastic Leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
45
|
4
|
0.020 |
None |
1.000 |
2 |
|
2008 |
2018 |
5q-syndrome
|
disease |
Pathological Conditions, Signs and Symptoms; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
45
|
1
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
CML progression
|
disease |
|
Neoplastic Process
|
47
|
3
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Refractory anaemia with excess blasts
|
disease |
Hemic and Lymphatic Diseases
|
Neoplastic Process
|
49
|
2
|
0.020 |
None |
1.000 |
2 |
|
1994 |
1995 |
acute myeloid leukemia with multilineage dysplasia following myelodysplastic syndrome
|
disease |
|
Neoplastic Process
|
49
|
1
|
0.020 |
None |
1.000 |
2 |
|
2012 |
2015 |
Childhood Pre-B Acute Lymphoblastic Leukemia
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
51
|
3
|
0.010 |
None |
1.000 |
1 |
|
1998 |
1998 |
Systolic blood pressure measurement
|
phenotype |
|
Diagnostic Procedure
|
54
|
95
|
0.100 |
None |
1.000 |
3 |
4
|
2009 |
2018 |
Myeloid neoplasm
|
disease |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
62
|
5
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
PROSTATE CANCER, HEREDITARY, 1
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
62
|
2
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Colon adenoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
63
|
1
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Treatment related acute myeloid leukaemia
|
disease |
|
Neoplastic Process
|
65
|
4
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Respiratory Function Tests
|
phenotype |
|
Diagnostic Procedure
|
67
|
108
|
0.100 |
None |
1.000 |
1 |
1
|
2011 |
2011 |
Radioulnar Synostosis
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases
|
Congenital Abnormality
|
67
|
|
0.110 |
None |
1.000 |
1 |
|
2018 |
2018 |
Leukemia, Myeloid, Chronic-Phase
|
disease |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
72
|
1
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Cytokine Measurement
|
phenotype |
|
Laboratory Procedure
|
82
|
123
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Adult Lymphoblastic Lymphoma
|
disease |
|
Neoplastic Process
|
85
|
4
|
0.010 |
None |
1.000 |
1 |
|
1998 |
1998 |
Childhood Lymphoblastic Lymphoma
|
disease |
|
Neoplastic Process
|
85
|
4
|
0.010 |
None |
1.000 |
1 |
|
1998 |
1998 |
Precursor cell lymphoblastic lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
88
|
4
|
0.010 |
None |
1.000 |
1 |
|
1998 |
1998 |